CAPA to Present Two Posters at the 2026 CRA Annual Scientific Meeting

The Canadian Arthritis Patient Alliance is pleased to be presenting two posters at the 2026 Canadian Rheumatology Association Annual Scientific Meeting, taking place April 16–19 in Halifax. CAPA’s President, Linda Wilhelm, will be attending the conference and...

New Report Highlights Impact of Drug Shortages on People Living with Arthritis Across Canada

Ottawa, ON — March 25, 2026 — As global pharmaceutical supply chains face growing pressure from geopolitical tensions, trade disruptions, and evolving industrial policies, a new report from the Canadian Arthritis Patient Alliance (CAPA) highlights how these systemic...

CAPA at the Clinical Trials Symposium 2026

CAPA Board member Lucy Kovalova-Woods and Patient Partner in Research Linda Hunter, MScN, PhD (C), presented a poster titled “A Practical Framework for Meaningful Patient Partner Engagement in Clinical Trials” at the Clinical Trials Symposium on February 17, 2026. The...

Getting on a Biologic Medication

We invite you to an free webinar “Getting on a Biologic Medication” on Tuesday, March 31, 2026 at 6:00 PM EDT to explore the journey and steps involved in starting a biologic medication for arthritis—from the initial conversation with a rheumatologist...

CAPA’s Feedback on Health Canada’s Consultation on the Removal of the Reconsideration Process (NOC/c)

The Canadian Arthritis Patient Alliance (CAPA) provided input to Health Canada on the proposed removal of the reconsideration process for Priority Review and Advance Consideration under the Notice of Compliance with Conditions (NOC/c) policy. In its submission, CAPA...